Microaggression Impact Assessment for Smoking Behavior
Trial Summary
What is the purpose of this trial?
The purpose of this study is to examine whether microaggressions relate to multimodal facets of smoking behavior, subjective withdrawal, and urge/craving. Additionally, the second aim is to examine whether smoking deprivation moderates the relation between microaggressions and multiple facets of smoking behavior, subjective withdrawal, and urge/craving.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Microaggression Recall and Relapse Analogue Task for smoking behavior?
The study on nicotine deprivation and attentional bias suggests that addressing discrimination-related stressors, like microaggressions, could be important in smoking interventions for African American adults. This implies that treatments focusing on microaggression recall might help reduce smoking by managing stress and attentional biases linked to discrimination.12345
How does the treatment in the Microaggression Impact Assessment for Smoking Behavior trial differ from other smoking cessation treatments?
This treatment is unique because it focuses on the impact of microaggressions (subtle, often unintentional discriminatory comments or actions) on smoking behavior, which is not typically addressed in standard smoking cessation treatments. It may explore how these social and emotional factors influence smoking habits, offering a novel approach compared to traditional methods that primarily target nicotine addiction or behavioral cues.678910
Research Team
Brooke Y Kauffman, Ph.D.
Principal Investigator
University of Houston
Eligibility Criteria
This trial is for Hispanic or Latino adults who smoke at least 5 cigarettes a day, have been smoking regularly for over a year, and have experienced microaggressions in the past 6 months. Participants must be at least 18 years old and able to give informed consent. Those with active suicidal thoughts cannot join.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Experimental Sessions
Participants attend two counterbalanced experimental sessions: Smoking Deprivation (16 hours of smoking abstinence) and Smoking as Usual.
Follow-up
Participants are monitored for safety and effectiveness after experimental sessions
Treatment Details
Interventions
- Microaggression Recall and Relapse Analogue Task (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Houston
Lead Sponsor
Norman Sussman
University of Houston
Chief Medical Officer since 2020
MD from Baylor College of Medicine
Tom Luby
University of Houston
Chief Executive Officer since 2019
PhD in Immunology from the Sackler School of Biomedical Sciences, Tufts University